Epoprostenol Delivered via High Flow Nasal Cannula for ICU Subjects with Severe Hypoxemia Comorbid with Pulmonary Hypertension or Right Heart Dysfunction

Inhaled epoprostenol (iEPO) has been utilized to improve oxygenation in mechanically ventilated subjects with severe hypoxemia, but the evidence for iEPO via high-flow nasal cannula (HFNC) is rare. Following approval by the institutional review board, this retrospective cohort study evaluated subjec...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Harnois, Lauren J., Markos, Bethelhem, Roberts, Keith M., Homoud, Salma Al, Liu, Jing, Mirza, Sara, Vines, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631264/
https://www.ncbi.nlm.nih.gov/pubmed/31207936
http://dx.doi.org/10.3390/pharmaceutics11060281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631264/
https://www.ncbi.nlm.nih.gov/pubmed/31207936
http://dx.doi.org/10.3390/pharmaceutics11060281

Ejemplares similares